journal article·2023-04

Egg Microneedle for Transdermal Delivery of Active Liraglutide

Jeongyun You, Seorin Juhng, Jieun Song, Jihyun Park, Mingyu Jang, Geonwoo Kang, Huisuk Yang, Hye Su Min, Jiwoo Shin, Seri Lee, Hyuk Wan Ko, Hyungil Jung

Advanced Healthcare Materials· Volume 12· Issue 9
Publisher page

Abstract

Abstract Liraglutide, a human glucagon‐like peptide‐1 (GLP‐1) analog, is promising for safely treating type 2 diabetes mellitus (T2DM), compared to insulin, by significantly reducing the risk of glucose‐dependent hypoglycemia. Concerns related to injection prevent T2DM patients from taking liraglutide regularly, even though once‐a‐day subcutaneous (SC) injections. Dissolving microneedles (DMNs) are promising substitutes for SC injection and for improving patient convenience. However, there are two fundamental limitations: the low drug delivery due to incomplete insertion and loss of drug activity during DMN fabrication. Here, it is shown that an egg microneedle (EMN) designed with three functional layered structures can maintain the maximum activity of the loaded compound during DMN fabrication and deliver it completely into the skin, with the base layer allowing the complete delivery of liraglutide, and the shell layer maintaining the drug activity by mimicking the role of albumin in eggs. In a diabetic mouse model, liraglutide administration via EMN exhibited similar effect when compared to that of injection. Therefore, EMN‐mediated liraglutide administration is a good potential option for replacing liraglutide injections in T2DM treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Dermatology and Skin Diseases · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biotechnology Yonsei University Building 123, 50 Yonsei‐ro Seodaemun‐gu Seoul 03722 Korea

Department of Biochemistry College of Life Science and Biotechnology Yonsei University 50 Yonsei‐ro Seodaemun‐gu Seoul 03722 Korea

Juvic Inc 272 Digital‐ro Guro‐gu Seoul 08389 Korea

Funding

National Research Foundation of Korea

References (32)

Show source-provided references
1. 10.1016/S0140-6736(17)30058-210.1016/S0140-6736(17)30058-2 ↗
2. 10.1016/S0140-6736(09)60659-010.1016/S0140-6736(09)60659-0 ↗
3. 10.1111/j.1464-5491.2009.02666.x10.1111/j.1464-5491.2009.02666.x ↗
4. 10.1016/j.biopha.2018.10.07810.1016/j.biopha.2018.10.078 ↗
5. 10.3390/pharmaceutics704043810.3390/pharmaceutics7040438 ↗
6. 10.1016/j.addr.2012.04.00510.1016/j.addr.2012.04.005 ↗
7. 10.1002/smll.20100109110.1002/smll.201001091 ↗
8. 10.1007/s11095-010-0192-910.1007/s11095-010-0192-9 ↗
9. 10.1021/acsami.8b1292610.1021/acsami.8b12926 ↗
10. 10.1016/j.ejps.2014.09.01110.1016/j.ejps.2014.09.011 ↗
11. 10.1007/s11095-010-0134-610.1007/s11095-010-0134-6 ↗
12. 10.1007/s00542-018-3780-y10.1007/s00542-018-3780-y ↗
13. 10.1002/jbm.a.3586910.1002/jbm.a.35869 ↗
14. 10.1016/j.jconrel.2010.10.03310.1016/j.jconrel.2010.10.033 ↗
15. 10.3390/pharmaceutics1108040210.3390/pharmaceutics11080402 ↗
16. 10.1002/978111995968710.1002/9781119959687 ↗
17. 10.1021/acsnano.7b0815210.1021/acsnano.7b08152 ↗
18. 10.1016/j.actbio.2019.12.03710.1016/j.actbio.2019.12.037 ↗
19. 10.1038/s41551-020-00650-410.1038/s41551-020-00650-4 ↗
20. 10.1016/j.msec.2017.11.00910.1016/j.msec.2017.11.009 ↗
21. 10.1038/s41551-018-0337-410.1038/s41551-018-0337-4 ↗
22. 10.1007/s13346-016-0282-210.1007/s13346-016-0282-2 ↗
23. 10.3389/fendo.2019.0015510.3389/fendo.2019.00155 ↗
24. 10.3390/pharmaceutics1111059910.3390/pharmaceutics11110599 ↗
25. 10.1002/adhm.20170032610.1002/adhm.201700326 ↗
26. 10.1210/en.2007-120010.1210/en.2007-1200 ↗
27. 10.1002/jps.2372410.1002/jps.23724 ↗
28. 10.1016/j.jconrel.2005.02.00210.1016/j.jconrel.2005.02.002 ↗
29. Center for Drug Evaluation and Research Application Number: 206321Orig1s000 U. S. Food and Drug Administration Silver Spring MD2014.
30. 10.3390/pharmaceutics1211106710.3390/pharmaceutics12111067 ↗
31. 10.1016/j.ejps.2017.12.02510.1016/j.ejps.2017.12.025 ↗
32. 10.1016/j.mpmed.2014.09.00710.1016/j.mpmed.2014.09.007 ↗